Safety evaluation and therapeutic efficacy of Habb-e-Asgand, a commonly used antirheumatic polyherbal Unani formulation

Alternative Therapies in Health and Medicine

Volumn 19, Issue 5, 2013, Pages 52-59

  Subramaneyaan, Mythily ^a   Yasmeen, Shagufta ^a   Arora, Vinod K ^a   Tripathi, Asok K ^a   Banerjee, Basu D ^a   Ahmed, Rafat S ^a  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; AUTOANTIBODY; METHOTREXATE; PLANT EXTRACT;

ALTERNATIVE MEDICINE; ANIMAL; ARTHRITIS; ARTICLE; BLOOD; DRUG EFFECT; FEMALE; IMMUNOLOGY; MALE; RANDOMIZATION; RAT; RHEUMATOID ARTHRITIS; WEIGHT GAIN; WISTAR RAT;

ANIMALS; ANTIRHEUMATIC AGENTS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; FEMALE; MALE; MEDICINE, UNANI; METHOTREXATE; PLANT EXTRACTS; RANDOM ALLOCATION; RATS; RATS, WISTAR; WEIGHT GAIN;

EID: 84884200170     PISSN: 10786791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Taneja V, Krco CJ, Behrens MD, Luthra HS, Griffiths MM, David CS. B cells are important as antigen presenting cells for induction of MHC-restricted arthritis in transgenic mice. Mol Immunol. 2007;44(11):2988-2996.
2. Emery P. Treatment of rheumatoid arthritis. BMJ. 2006;332(7534):152-155.
3. Husain A, Sofi GD, Tajuddin, Dang R, Kumar N. Unani system of medicine-introduction and challenges. Med J Islam World Acad Sci. 2010;18(1):27-30.
4. Arzani A. Tibb-e-Akbar. Delhi: Idara-Mutboat-e-Sulaimani. 1890:575-578.
5. Said HM, ed. Hamdard Pharmacopoeia of Eastern Medicine. New Delhi, India: Sri Satguru Publications; 1997.
6. Ahmad B, Akhtar J. Unani system of medicine. Pharmacogn Rev. 2007;1(2):210-214.
7. Zarnigar, Riaz A. Clinical efficacy of Al Hijamah (cupping) in Wajaul Mafasil Muzmin (osteoarthritis). Indian J Tradit Knowl. 2011;10(2):327-329.
8. Chatterjee A, Pakrashi SC, eds. The Treatise on Indian Medicinal Plants. New Delhi, India: National Institute of Science Communication and Information Resources; 1994.
9. Bone K. Clinical Applications of Ayurvedic and Chinese Herbs: Monographs for the Western Herbal Practitioner. Warwick, Australia: Phytotherapy Press; 1996:137-141.
10. Funk JL, Frye JB, Oyarzo JN, Timmermann BN. Comparative effects of two gingerol-containing Zingiber officinale extracts of experimental rheumatoid arthritis. J Nat Prod. 2009;72(3):403-407.
11. Battu GR, Kumar BM. Anti-inflammatory activity of leaf extract of Asparagus racemosus willd. Int J Chem Sci. 2010;8(2):1329-1338.
12. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008;22(3):659-661.
13. Drabkin DL, Austin JH. Spectrophotometric constants for common hemoglobin derivatives in human, dog, and rabbit blood. J Biol Chem. Aug 1932;98:719-733.
14. Fawcett JK, Scott JE. A rapid and precise method for the determination of urea. J Clin Pathol. March 1960;13:156-159.
15. Slot C. Plasma creatinine determination: a new and specific Jaffe reaction method. Scand J Clin Lab Invest. 1965;17(4):381-387.
16. Wilkinson JH, Boutwell JH, Winsten S. Evaluation of a new system for the kinetic measurement of serum alkaline phosphatase. Clin Chem. 1969;15(6):487-495.
17. Bradley DW, Maynard JE, Emery G, Webster H. Transaminase activities in serum of long-term hemodialysis patients [letter]. Clin Chem. 1972;18(11):1442.
18. Tietz NW. Textbook of Clinical Chemistry. Philadelphia, PA: Saunders; 1986.
19. Doumas BT, Arends RL, Pinto PC. Determination of serum albumin. In: Standard Methods of Clinical Chemistry. Chicago, IL: Academic Press; 1972:175-189.
20. Jendrassik L, Grof P. Colorimetric method of determination of bilirubin. Biochem Z. 1938;297:81-82.
21. Culling CF. Handbook of Histopathological and Histochemical Techniques. 3rd ed. Waltham, MA: Butterworth-Heinemann; 1974.
22. Hultqvist M, Olofsson P, Gelderman KA, Holmberg J, Holmdahl R. A new arthritis therapy with oxidative burst inducers. PLOS Med. 2006;3(9):e348.
23. Campo GM, Avenoso A, Campo S, Ferlazzo AM, Altavilla D, Calatroni A. Efficacy of treatment with glycosaminoglycans on experimental collagen-induced arthritis in rats. Arthritis Res Ther. 2003;5(3):R122-R131.
24. Holmdahl R, Carlsen S, Mikulowska A, et al. Genetic analysis of mouse models for rheumatoid arthritis. In: Adolph KW, ed. Human Genome Methods. New York, NY: CRC Press; 1998:215-240.
25. Bendele A. Animal models of rheumatoid arthritis. J Musculoskelet Neuronal Interact. 2001;1(4):377-385.
26. De Rycke L, Peene I, Hoffman IE, et al. Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann Rheum Dis. 2004;63(12):1587-1593.
27. Vierboom MP, Zavodny PJ, Chou CC, et al. Inhibition of the development of collagen-induced arthritis in rhesus monkeys by a small molecular weight antagonist of CCR5. Arthritis Rheum. 2005;52(2):627-636.
28. Calabrese LH. Molecular differences in anticytokine therapies. Clin Exp Rheumatol. 2003;21(2):241-248.
29. Louie SG, Park B, Yoon H. Biological response modifiers in the management of rheumatoid arthritis. Am J Health Syst Pharm. 2003;60(4):346-355.
30. Lubeck DP. A review of the direct costs of rheumatoid arthritis: managed care versus fee-for-service settings. Pharmacoeconomics. 2001;19(8):811-818.
31. Lambert CM. Medical therapy for rheumatoid arthritis-value for money? Rheumatology (Oxford). 2001;40(9):961-964.
32. Biologics Cost Comparison. In: Consumer Reports Health Best Buy Drugs: Evaluating Prescription Drugs Used to Treat the Symptoms of Rheumatoid Arthritis: The Biologics. Yonkers, NY: Consumers Union; 2010:9.